Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2025-12-24 @ 11:08 PM
NCT ID:
NCT02158169
Eligibility Criteria:
Inclusion Criteria:
* Adult patients, aged 18 years and older, seen by the oncologist or hematologist for chemotherapy.
* Patients for whom the oncologist or hematologist has decided the initiation of an epoetin alpha biosimilar treatment (Retacrit®) for anemia.
* Patients informed about the computer processing of their medical data and their right of access and correction.
Exclusion Criteria:
* Patients with hemoglobin concentrations \>11 g/dL.
* Patients who have been transfused within the previous month.
* Patients who are hypersensitive to erythropoietin or one of its excipients.
* Patients participating or having participated in the previous month in a clinical trial in the field of anaemia in oncology.
* Patients refusing to participate in the observational study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02158169
Study Brief:
Protocol Section:
NCT02158169